Qmed News

Getting your medical device to market

Clinical Affairs
Medical Design Control Processes: Where to start! – A top level Overview.
September 18, 2023
Helene Quie, CEO at Qmed Consulting A/S

The development and manufacture of medical devices require stringent design control processes to ensure their safety, effectiveness, and compliance with regulatory standards. This white paper provides an in-depth examination of medical design control processes, with a particular focus on the International Organization for Standardization (ISO) 13485 standard, other relevant standards and the Medical Device Regulation (MDR). The paper discusses key concepts, stages, and activities involved in design control, along with the regulatory requirements imposed by the standards and the MDR. By adhering to these standards, medical device manufacturers can streamline their design processes and enhance patient safety and product quality.

Clinical Affairs
MEDDEV 2.7/1 Rev 4 Clinical Evaluation: Are you ready to update your clinical evaluation report.
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

A new version of the European Guideline MEDDEV 2.7/1 rev 4 was issued in June 2016 affecting all companies that market medical devices in Europe. This guidance promotes a common approach to clinical evaluation for medical devices regulated by the directives 93/42/EEC...

Clinical Affairs
Are your sites prepared for FDA inspection of your clinical investigations in EU?
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

FDA’s Compliance Program Manual provides Inspectors with instructions for evaluating industry compliance with regulations and Good Clinical Practice (GCP). Among other activities, the FDA Bioresearch Monitoring (BIMO) Program involves site visits to clinical investigators, sponsors, monitors, contract research organizations...

Clinical Affairs
Are your investigator and site ready for an FDA inspection? - Part 2
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

FDA’s Compliance Program Manual provides Inspectors with instructions for evaluating industry compliance with regulations and Good Clinical Practice (GCP). Among other activities, the FDA Bioresearch Monitoring (BIMO) Program involves site visits to clinical investigators, sponsors, monitors, contract research organizations, nonclinical (animal) laboratories, and...

Clinical Affairs
The new Medical Device Regulation – and its impact on innovation
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

Last week the European commission published the new Medical Device Regulation (MDR) and the question on how this will impact the Medical Device industry within Europe have been asked by many. The purpose of this new regulation is to ensure...

Clinical Affairs
Are you our new CRA?
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

Do you have a solid clinical research background? Do you want to drive clinical trials in a company that ensures reliable and thorough approvals for new medical devices? As our new clinical research associate (CRA), you will embark on an exciting and collaborative career...

Clinical Affairs
Case Story - Investigator Initiated Studies
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

An organisation may fund research without being the Clinical Sponsor. A Clinical Sponsor is the responsible party for a study or investigation and is per definition defines as...

Clinical Affairs
How to determine what Post Market Clinical Follow-up activities to initiate?
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

With the Medical Device Regulation coming fully into force on 26 May 2020, there is a risk that a majority of the medical devices on the European market converting from the Medical Device Directive into the new Regulation will be considered by the Authorities and Notified Bodies to have insufficient clinical evidence to support their continued...

Clinical Affairs
As healthcare professional or institute - what does the new medical device regulation change for you?
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

The publication of the MDR in May 2017 marked the start of a 3 year period of transition from the MDD and the AIMDD. During the transition period the Regulations will come into force gradually, starting with provisions related to the designation of Notified Bodies and the ability of manufacturers to apply for new certificates under the Regulations...

Clinical Affairs
The revision of ISO 14155 is available
April 26, 2023
Helene Quie, CEO at Qmed Consulting A/S

The final draft of the new third edition of the ISO 14155 is being prepared for circulation. This means that at the present stage, only editorial changes are permitted, and therefore this draft version can be used by sponsors designing clinical investigations of medical devices...

istockphoto-1297604574-612x612-1.jpg
No Approach Fits All Clinical Evaluations.
October 20, 2022
Bassil Akra & Qmed Consulting

Our newest article is a result of an interview by Helene Quie to Bassil Akra, AKRA TEAM's CEO, on the subject of Clinical Evaluations.

Capture.jpg
The Use Scientific Surveys as a Method to Collect Medical Device Clinical Evidence
August 3, 2022
Helene Quie & Søren Underbjerg

Our newest article is a result of an interview by Helene Quie to Søren Underbjerg, Qmed Consulting's Team Lead for Clinical Development and Market Access, on "The Use Scientific Surveys as a Method to Collect Medical Device Clinical Evidence".

brexit.png
News from the UK
December 11, 2020
Helene Quie, CEO at Qmed Consulting A/S

The transition period for the United Kingdom to leave the European Union is coming to an end on 31 December 2020. After the deadline UK will be considered a third country if no...

switzerland.jpg
News from Switzerland
October 7, 2020
Helene Quie, CEO at Qmed Consulting A/S

In Switzerland, just as elsewhere, ‘Europe’ and immigration are closely connected topics. The right wing political party is very vocal in its campaigning to reduce the numbers o...

qabc.jpg
NEW – The Qmed Academy Book Club
May 19, 2020
Helene Quie, CEO at Qmed Consulting A/S

Important new MDCG guidelines are released from the European Commission. These are importance guidance documents for all of us working within developing and selling medical devices...

Clinical Affairs
MDCG Guidance
May 13, 2020
Helene Quie, CEO at Qmed Consulting A/S

The pandemic COVID-19 has resulted in various restrictions to countries around the globe. It has affected the ability of notified bodies to conduct mandatory on-site audits unde...

Clinical Affairs
How to Spend the Time
May 13, 2020
Helene Quie, CEO at Qmed Consulting A/S

Several guidance’s, posts, webinars have been published addressing what evidence collection due to the COVID-19 pandemic, and with this Newsletter we are publishing where to find the different national guidelines and recommendations. Additionally, the MDR Amendment allow us to reconsider our strategies and potential scenarios. In this article...

sum.png
Sum up of the new MDR amendment from The European Parliament
April 8, 2020
Helene Quie, CEO at Qmed Consulting A/S

While we are waiting for the MDR amendment to be discussed and agreed upon by the European Parliament and the Council hopefully before end May through an accelerated co-decision procedure lets try and sum up what it could mean for manufacturers of medical devices (note: As for the In Vitro Diagnostics Regulation (IVDR), which will be applicable from 26 May...

covid.png
Covid-19: Letter from Qmed management
April 8, 2020
Helene Quie, CEO at Qmed Consulting A/S

As the impact of COVID-19 intensifies globally, governments and healthcare systems come under extraordinary pressure. And healthcare professionals are holding the front line to save lives...